Abstract: To improve the detection of LSD, and LSD metabolites in biological samples, antibodies are raised to 2-oxo-3-hydroxy-LSD conjugated to a protein carrier. Selected antibodies are matched with an immunoassay reagent in which the 2-oxo-3-hydroxy-LSD is conjugated in the same position to a labeling or separation means. The set of reagents can be used in immunoassays for detecting or confirming the presence of LSD or LSD metabolites in a sample potentially containing interfering substances.
Type:
Grant
Filed:
June 16, 2000
Date of Patent:
April 15, 2003
Assignee:
Microgenetics Corporation
Inventors:
Anthony de Jesus Sanchez, David Davoudzadeh, William A. Coty